B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias

Heart Rhythm

Volumn 11, Issue 7, 2014, Pages 1109-1116

  Levine, Yehoshua C ^a   Rosenberg, Michael A ^b   Mittleman, Murray ^a   Samuel, Michelle ^a   Methachittiphan, Nilubon ^c   Link, Mark ^c   Josephson, Mark E ^a   Buxton, Alfred E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

BNP; ICD; NT proBNP; Sudden cardiac death; Ventricular arrhythmias

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATININE; NITROGEN; UREA; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DEFIBRILLATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; UREA NITROGEN BLOOD LEVEL; BLOOD; CLINICAL TRIAL; DEATH, SUDDEN, CARDIAC; MIDDLE AGED; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL; TACHYCARDIA;

AGED; BIOLOGICAL MARKERS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TACHYCARDIA;

EID: 84903127341     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.04.024     Document Type: Article

References (30)

1. D. Lloyd-Jones, R. Adams, and T. Brown et al. Heart disease and stroke statistics - 2010 update Circulation 121 2010 e1 e170
2. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 117 2008 e350
3. J.J. Goldberger, M.E. Cain, and S.H. Hohnloser et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention Heart Rhythm 5 2008 e1 e21
4. A.P.M. Gorgels, C. Gijsbers, J. de Vreede-Swagemakers, A. Lousberg, and H.J. Wellens The Maastricht Circulatory Arrest Registry. Out-of-hospital cardiac arrest - the relevance of heart failure Eur Heart J 24 2003 1204 1209
5. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease New Engl J Med 341 1999 1882 1890
6. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews MADIT-II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction New Engl J Med 346 2002 877 883
7. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure New Engl J Med 352 2005 225
8. A.E. Buxton Implantable cardioverter-defibrillators for primary prevention of sudden death: the quest to identify patients most likely to benefit J Am Coll Cardiol 60 2012 1656 1658
9. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
10. D.J. van Veldhuisen, G.C. Linssen, T. Jaarsma, W.H. van Gilst, A.W. Hoes, J.G. Tijssen, W.J. Paulus, A.A. Voors, and H.L. Hillege B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J Am Coll Cardiol 61 2013 1498 1506
11. W. Whang, M.A. Mittleman, D.Q. Rich, P.J. Wang, J.N. Ruskin, G.H. Tofler, J.E. Muller, and C.M. Albert Heart failure and the risk of shocks in patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study Circulation 109 2004 1386 1391
12. A.A. Hussein, W.I. Saliba, and D.O. Martin et al. Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation Circulation 123 2011 2077 2082
13. R. Sharif-Naeini, J.H. Folgering, D. Bichet, F. Duprat, P. Delmas, A. Patel, and E. Honore Sensing pressure in the cardiovascular system: Gq-coupled mechanoreceptors and TRP channels J Mol Cell Cardiol 48 2010 83 89
14. S. Wel, N.I. Loyo-Berrios, M.C. Haigney, H. Cheng, E.E. Pinnow, K.R. Mitchell, J.H. Beachy, A.M. Woodward, Y. Wang, J.P. Curtis, and D. Marinac-Dabic Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation Circ Cardiovasc Qual Outcomes 4 2011 346 354
15. P.A. Scott, J. Barry, P.R. Roberts, and J.M. Morgan Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis Eur J Heart Fail 11 2009 958 966
16. A. Verma, F. Kilicaslan, and D.O. Martin et al. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies Heart 92 2006 190 195
17. O. Galante, G. Amit, D. Zahger, A. Wagshal, R. Ilia, and A. Katz B-type natriuretic peptide levels stratify the risk for arrhythmia among implantable cardioverter defibrillator patients Clin Cardiol 31 2008 586 589
18. H. Yu, H. Oswald, A. Gardiwal, C. Lissel, and G. Klein Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction Am J Cardiol 100 2007 635 639
19. R. Berger, M. Huelsman, K. Strecker, A. Bojic, P. Moser, B. Stanek, and R. Pacher B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
20. K.K. Patton, N. Sotoodehnia, C. DeFilippi, D.S. Siscovick, J.S. Gottdiener, and R.A. Kronmal N-terminal pro-B-type natriuretic peptide is associated with sudden death risk: the Cardiovascular Health Study Heart Rhythm 8 2011 228 233
21. J.M. Tapanainen, K.S. Lindgren, T.H. Mäkikallio, O. Vuolteenaho, J. Leppaluoto, and H.V. Huikuri Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era J Am Coll Cardiol 43 2004 757
22. S.W. Waldo, J. Beede, S. Isakson, S. Villard-Saussine, J. Fareh, P. Clopton, R.L. Fitzgerald, and A.S. Maisel Pro-B-type natriuretic peptide levels in acute decompensated heart failure J Am Coll Cardiol 51 2008 1874 1882
23. W. Grimm, J. Hoffmann, H. Muller, and B. Maisch Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30% J Am Coll Cardiol 39 2002 780 787
24. H. Blangy, N. Sadoul, B. Dousset, A. Radauceanu, R. Fay, E. Aliot, and F. Zannad Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction Europace 9 2007 724 729
25. K. Tigen, T. Karaahmet, G. Kahveci, A.C. Tanalp, H. Fotbolcu, F. Bayrak, B. Mutlu, and Y. Basaran N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm Heart Lung Circ 16 2007 290 294
26. P.J. Zimetbaum, A.E. Buxton, W. Batsford, J.D. Fisher, G.E. Hafley, K.L. Lee, M.F. O'Toole, R.L. Page, M. Reynolds, and M.E. Josephson Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial Circulation 110 2004 766 769
27. K. Winkler, C. Wanner, C. Drechsler, J. Lilienthal, W. Marz, and V. Krane Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients Eur Heart J 29 2008 2092 2099
28. 2+ transients A. Kamkin, I. Kiseleva, e. Mechanosensitivity in Cells and Tissues 2005 Academia Moscow, Russia
29. B.L. Wilkoff, B.D. Williamson, R.S. Stern, S.L. Moore, F. Lu, S.W. Lee, U.M. Birgersdotter-Green, M.S. Wathen, I.C. Van Gelder, B.M. Heubner, M.L. Brown, and K.K. Holloman Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study J Am Coll Cardiol 52 2008 541 550
30. K.A. Ellenbogen, J.H. Levine, R.D. Berger, J.P. Daubert, S.L. Winters, E. Greenstein, A. Shalaby, A. Schaechter, H. Subacius, and A. Kadish Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 2006 776 782